Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease
Aliment Pharmacol Ther
.
2024 Oct;60(8):1139-1140.
doi: 10.1111/apt.18220.
Epub 2024 Sep 2.
Authors
Jannis Kountouras
1
,
Elisabeth Vardaka
1
2
,
Christos Zavos
1
,
Dimitrios Chatzopoulos
1
,
Maria Tzitiridou-Chatzopoulou
1
3
,
Dimitrios Tzilves
4
,
Georgia Zournatzidou
5
,
Foteini Kyrailidou
1
,
Maria C Mouratidou
1
Affiliations
1
Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
2
Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Thessaloniki, Greece.
3
Midwifery Department, School of Healthcare Sciences, University of West Macedonia, Koila, Kozani, Greece.
4
Gastroenterology Department, Theageneio Hospital, Thessaloniki, Greece.
5
Department of Business Administration, University of Western Macedonia, Kozani, Greece.
PMID:
39223754
DOI:
10.1111/apt.18220
No abstract available
Publication types
Letter
MeSH terms
Chronic Disease
Esophageal Diseases / microbiology
Helicobacter Infections* / complications
Helicobacter pylori*
Humans
Liver Diseases / complications
Liver Diseases / microbiology